Formulations with anti-tumour action
US8551967B2 · kind B2 · utility
8Cited by
14References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2006 |
| Grant date | Oct 8, 2013 |
| Priority date | — |
| Expiry date | Oct 8, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of defibrotide as an anti-tumor agent, alone or in combination with other active ingredients with anti-tumor action, is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.